Lymphocytic leukaemia | Myelogrenous leukaemia | Other leukaemia* | ||||||
---|---|---|---|---|---|---|---|---|
Total | Acute | Chronic | Total | Acute | Chronic | |||
*All other leukaemia including unspecified leukaemia. | ||||||||
All subjects | Obs/exp | 19/14.8 | 1/2.4 | 16/10.6 | 28/22.0 | 14/13.7 | 11/6.6 | 18/14.6 |
SMR | 128 | 42 | 151 | 127 | 102 | 167 | 123 | |
(95% CI) | (77–200) | (1–234) | (87–247) | (84–183) | (56–171) | (83–299) | (73–194) | |
Ever hourly | Obs/exp | 17/12.3 | 1/2.0 | 15/8.8 | 24/18.3 | 11/11.3 | 11/5.5 | 17/12.2 |
SMR | 138 | 51 | 171 | 131 | 97 | 200 | 139 | |
(95% CI) | (80–221) | (1–282) | (96–281) | (84–195) | (48–173) | (100–358) | (81–222) | |
Never hourly | Obs/exp | 2/2.5 | 0/0.4 | 1/1.8 | 4/3.8 | 3/2.4 | 0/1.1 | 1/2.4 |
SMR | 81 | 0 | 57 | 106 | 127 | 0 | 42 | |
(95% CI) | (10–293) | (0–913) | (1–319) | (29–271) | (26–370) | (0–338) | (1–231) |